Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03684486
What this trial is testing

Rehabilitation by Effort for Patients With Advanced Bronchial Cancer

Who this might be right for
Bronchial CancerMalignant Mesothelioma
University Hospital, Toulouse 19
Testing effectiveness (Phase 2)Study completedNCT00165516
What this trial is testing

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Who this might be right for
Pleural MesotheliomaMalignant Pleural Mesothelioma
Dana-Farber Cancer Institute 85
Testing effectiveness (Phase 2)Study completedNCT00004033
What this trial is testing

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
NYU Langone Health 30
Early research (Phase 1)Study completedNCT04672434
What this trial is testing

Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 48
Early research (Phase 1)Looking for participantsNCT07705334
What this trial is testing

SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsTriple Negative Breast Cancer (TNBC)HR+ Breast Cancer+8 more
SHY Therapeutics 30
Not applicableEnded earlyNCT02648763
What this trial is testing

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 33
Testing effectiveness (Phase 2)UnknownNCT00886028
What this trial is testing

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
National Institute of Cancerología 31
Early research (Phase 1)Study completedNCT00003263
What this trial is testing

Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
Fox Chase Cancer Center 6
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Testing effectiveness (Phase 2)Study completedNCT00392444
What this trial is testing

Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Advanced Malignant MesotheliomaRecurrent Malignant Mesothelioma
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)UnknownNCT00024271
What this trial is testing

Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer

Who this might be right for
Malignant Mesothelioma
Herbert Irving Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT05498597
What this trial is testing

AMT-151 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorAdvanced CancerAdvanced Carcinoma+16 more
Multitude Therapeutics Inc. 30
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Looking for participantsNCT05568680
What this trial is testing

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Who this might be right for
Ovarian CancerCholangiocarcinoma RecurrentMesothelioma, Malignant
Verismo Therapeutics 42
Testing effectiveness (Phase 2)Looking for participantsNCT07510815
What this trial is testing

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

Who this might be right for
Malignant Pleural Mesotheliomas
Beijing Biotech 36
Early research (Phase 1)Study completedNCT04537715
What this trial is testing

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Who this might be right for
All MalignanciesAdvanced MalignanciesHematologic Malignancy+9 more
Epizyme, Inc. 42
Testing effectiveness (Phase 2)UnknownNCT00002465
What this trial is testing

High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma

Who this might be right for
Breast CancerEndometrial CancerMalignant Mesothelioma
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT05324436
What this trial is testing

Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Bristol-Myers Squibb 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02414269
What this trial is testing

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Who this might be right for
Malignant Pleural DiseaseMesotheliomaMetastases+2 more
Memorial Sloan Kettering Cancer Center 113
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Next Page